Q3 EPS Estimate for Axon Enterprise Increased by Analyst

Posted by Geri Gentry on Aug 19th, 2026

Axon Enterprise, Inc (NASDAQ:AXON – Free Report) – Equities researchers at Northland Securities raised their Q3 2026 earnings per share (EPS) estimates for Axon Enterprise in a note issued to investors on Thursday, August 6th. Northland Securities analyst M. Latimore now anticipates that the biotechnology company will earn $1.01 per share for the quarter, up from their previous estimate of $0.85. The consensus estimate for Axon Enterprise’s current full-year earnings is $2.04 per share. Northland Securities also issued estimates for Axon Enterprise’s Q4 2026 earnings at $1.29 EPS, FY2026 earnings at $3.12 EPS, Q1 2027 earnings at $0.81 EPS, Q2 2027 earnings at $1.28 EPS, Q3 2027 earnings at $1.70 EPS, Q4 2027 earnings at $2.70 EPS and FY2027 earnings at $6.49 EPS.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last released its quarterly earnings data on Tuesday, August 4th. The biotechnology company reported $1.88 EPS for the quarter, beating the consensus estimate of $1.84 by $0.04. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.The firm had revenue of $904.39 million during the quarter, compared to the consensus estimate of $876.42 million. During the same quarter in the previous year, the company posted $2.12 earnings per share. The company’s quarterly revenue was up 35.3% on a year-over-year basis.

A number of other analysts have also commented on the stock. Zacks Research lowered shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 10th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Axon Enterprise in a research note on Wednesday, August 5th. Piper Sandler lifted their price objective on shares of Axon Enterprise from $724.00 to $732.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. Royal Bank Of Canada reissued an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, July 21st. Finally, Citizens Jmp restated a “market outperform” rating and issued a $700.00 target price on shares of Axon Enterprise in a report on Thursday, June 25th. Thirteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $730.92.

View Our Latest Stock Analysis on AXON

Axon Enterprise Price Performance

Shares of AXON opened at $619.85 on Monday. The business’s fifty day moving average is $532.07 and its 200 day moving average is $473.93. Axon Enterprise has a 12-month low of $339.01 and a 12-month high of $794.29. The company has a quick ratio of 1.80, a current ratio of 2.15 and a debt-to-equity ratio of 0.47. The stock has a market cap of $50.36 billion, a P/E ratio of 257.20, a P/E/G ratio of 9.95 and a beta of 1.39.

Institutional Investors Weigh In On Axon Enterprise

Several large investors have recently modified their holdings of AXON. Edgewood Management LLC bought a new position in Axon Enterprise during the fourth quarter worth about $846,516,000. Wellington Management Group LLP increased its stake in shares of Axon Enterprise by 326.9% in the fourth quarter. Wellington Management Group LLP now owns 1,539,738 shares of the biotechnology company’s stock worth $874,463,000 after purchasing an additional 1,179,038 shares in the last quarter. Norges Bank bought a new stake in shares of Axon Enterprise in the fourth quarter valued at approximately $515,764,000. Bank of America Corp DE bought a new stake in shares of Axon Enterprise in the second quarter valued at approximately $286,684,000. Finally, Legal & General Group Plc purchased a new stake in shares of Axon Enterprise during the 2nd quarter valued at approximately $244,669,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling

In related news, insider Isaiah Fields sold 2,000 shares of the firm’s stock in a transaction dated Friday, May 22nd. The shares were sold at an average price of $400.00, for a total transaction of $800,000.00. Following the completion of the sale, the insider owned 52,813 shares in the company, valued at approximately $21,125,200. This trade represents a 3.65% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Elizabeth Reid Coughlin sold 1,554 shares of Axon Enterprise stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $485.00, for a total transaction of $753,690.00. Following the completion of the sale, the insider directly owned 34,024 shares in the company, valued at approximately $16,501,640. This represents a 4.37% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 68,989 shares of company stock worth $36,016,932 in the last ninety days. Corporate insiders own 4.20% of the company’s stock.

About Axon Enterprise

(Get Free Report)

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.